PM&R Journal Club

Topics: Therapeutic effect of focused-extracorporeal shockwave therapy on muscular & adjacent tissue stiffness and pain in myofascial pain syndrome

Speakers: Scott Baumel

Topics: Targeting the GLP-1/GLP-1R axis to treat osteoarthritis: A new opportunity?

Speakers: Bryan K. Ganter, MD

Date: Wednesday, December 10, 2025
Time: 7:30 – 8:00 am
TEAMS link sent to staff

Learning Objectives
Upon completion of this activity, participants should be able to:

1. Examine the methodology, populations, and outcome measures of randomized sham-controlled trial assessing focused extracorporeal shockwave therapy (fESWT) for myofascial trigger points.
2. Interpret the relationship between objective tissue-level changes (elastography/mechanical stiffness) and patient-reported functional outcomes to guide clinical decision-making in sports and MSK medicine.
3. Appraise the strengths, limitations, and clinical applicability of fESWT as an adjunct treatment, and formulate evidence-based recommendations for athletes requiring symptom modulation or rapid return to play.
4. Describe the association of type 2 diabetes and OA.
5. Examine the physiologic function of GLP-1 and GLP-1R.
6. Evaluate the GLP-1/GLPR effects on joints/chondrocyte metabolism.
7. Project the future impact of GLP-1 and OA management.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.